World's Best Scientists 2026 revealed!
Marco Matucci-Cerinic

Marco Matucci-Cerinic

D-Index & Metrics

Medicine

D-Index
121
Citations
68566
World Ranking
3556
National Ranking
103

Overview

Marco Matucci-Cerinic is affiliated with the University of Florence in Italy. Their research work primarily spans the field of Medicine, with a strong focus on Rheumatology, Pulmonary and Respiratory Medicine, and Dermatology, among other subfields.

The main subfields of study for this scientist include:

  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine
  • Rheumatology
  • Dermatology
  • Epidemiology

Their work covers several major topics such as:

  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Dermatologic Treatments and Research
  • Inflammatory Myopathies and Dermatomyositis
  • Mast cells and histamine
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research

Marco Matucci-Cerinic has collaborated frequently with several co-authors including:

  • Cosimo Bruni
  • Silvia Bellando-Randone
  • Serena Guiducci
  • Lorenzo Dagna
  • Corrado Campochiaro

The scientist has published extensively in well-known academic journals. The most frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • The Lancet Rheumatology
  • Therapeutic Advances in Musculoskeletal Disease
  • Seminars in Arthritis and Rheumatism

Notable recent papers authored or co-authored by Marco Matucci-Cerinic cover a range of topics related to systemic sclerosis, immune response, and rheumatology. These include:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs, 2020, TURKISH JOURNAL OF MEDICAL SCIENCES
  • Raynaud phenomenon and digital ulcers in systemic sclerosis, 2020, Nature Reviews Rheumatology
  • EULAR recommendations for the treatment of systemic sclerosis: 2023 update, 2024, Annals of the Rheumatic Diseases
  • Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS), 2021, The Lancet Rheumatology

Marco Matucci-Cerinic has contributed to scholarly books as well, with publications through Frontiers Media including the title:

  • Pulmonary Fibrosis: One Manifestation, Various Diseases, 2022

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

    U A Walker;A Tyndall;L Czirják;C Denton

  • Prevalence of fibromyalgia: a survey in five European countries.

    Jaime C. Branco;Bernard Bannwarth;Inmaculada Failde;Jordi Abello Carbonell

  • Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

    J. H. Korn;Maureen D Mayes;M. Matucci Cerinic;M. Rainisio

  • EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

    O. Kowal-Bielecka;R. Landewé;J. Avouac;S. Chwiesko

  • Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial

    J.M. van Laar;D. Farge;J.K. Sont;K. Naraghi

  • Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

    Yehuda Shoenfeld;Roberto Gerli;Andrea Doria;Eiji Matsuura

  • Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    D. Aletaha;R.B. Landewe;T. Karonitsch;J. Bathon

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

    Marco Matucci-Cerinic;Christopher P Denton;Daniel E Furst;Maureen D Mayes

  • Mortality in systemic sclerosis: An international meta-analysis of individual patient data

    John P.A. Ioannidis;John P.A. Ioannidis;Panayiotis G. Vlachoyiannopoulos;Anna Bettina Haidich;Thomas A. Medsger

  • Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis

    Dinesh Khanna;Daniel E. Furst;Philip J. Clements;Yannick Allanore

  • Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri

  • Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

    X Mariette;M Matucci-Cerinic;K Pavelka;P Taylor

  • Review: evidence that systemic sclerosis is a vascular disease.

    Marco Matucci-Cerinic;Bashar Kahaleh;Fredrick M. Wigley

  • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Suzana Jordan;Jörg H W Distler;Britta Maurer;Dörte Huscher

  • COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

    Abdurrahman Tufan;Aslihan Avanoğlu Güler;Marco Matucci-Cerinic

Frequent Co-Authors

Yannick Allanore
Yannick Allanore Université Paris Cité
Christopher P. Denton
Christopher P. Denton University College London
Oliver Distler
Oliver Distler University of Zurich
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Ulf Müller-Ladner
Ulf Müller-Ladner University of Giessen
Paolo Airò
Paolo Airò University of Brescia
Janet E. Pope
Janet E. Pope University of Western Ontario
Gabriela Riemekasten
Gabriela Riemekasten University of Lübeck
Valeria Riccieri
Valeria Riccieri Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Medicine doesn’t always mean attending a traditional medical school in the USA. There are many affordable online pathways that can lead to impactful careers in healthcare. For those interested in healthcare administration, several universities now offer some of the cheapest mha programs online healthcare. These options allow you to develop management and leadership skills without high tuition costs.

If you are a nurse aiming to advance your career, consider enrolling in one of the least expensive dnp programs. These programs can help you achieve the highest level of clinical nursing practice while studying flexibly online.

Pharmacists can also benefit from remote study by considering pharm d online programs. These are designed for busy professionals who wish to further their expertise and credentials without leaving the workforce.

Finally, as electronic medical records become more essential, the demand for skilled health IT professionals is increasing. A health information technology online degree prepares you to manage patient data and support healthcare delivery in diverse settings.

Best Scientists Citing Marco Matucci-Cerinic

Trending Scientists